Julie Rovner, KFF Health News’ chief Washington correspondent and host of the What the Health? podcast, recently spoke with Sen. Tammy Baldwin (D-Wis.) about the...
The Food and Drug Administration (FDA) is implementing a new strategy to provide experimental gene therapies to patients with rare disorders without going through clinical...
Since his second term started, President Donald Trump has announced, negotiated, or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical...
The U.S. Food and Drug Administration (FDA) has approved the first-ever gene therapy for inherited deafness. The therapy, called Otarmeni, is approved to treat a...
The U.S. Food and Drug Administration (FDA) has approved a new GLP-1 weight-loss pill from drugmaker Eli Lilly, the agency said on Wednesday. The drug...
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly...